U.S. stock were set to open lower Monday, following European market declines, as Greece's prime minister promised to end austerity measures and as the country's finance minister warned a Greek exit would cause the collapse of the euro.
In an interview with Italian state television RAI, Greece's finance minister Yanis Varoufakis said "the euro is fragile" and will collapse like "a castle of cards" if Greece were to exit the Eurozone, Reuters reported.
Meanwhile, U.K. Prime Minister David Cameron and officials from the U.K. finance ministry and the Bank of England reportedly met Monday to plan for a possible Greek exit.
In economic data on tap this week, investors will closely watch the Labor Department's December Job Openings and Labor Turnover Survey out on Tuesday and the January retail sales report out on Thursday.
In equities, McDonald's ( MCD ) was lower 1% in recent pre-market trade after saying January global comparable store sales fell 1.8. Toy and game maker Hasbro ( HAS ) rose over 3% after adding $500 million to its share buyback program.
U.S. PRE-MARKET INDICATORS
-Dow Jones Industrial down 0.58%
-S&P 500 futures down 0.55%
-Nasdaq 100 futures down 0.50%
-Nasdaq-100 Pre-Market Indicator down 0.22%
Nikkei up 0.36%
Hang Seng down 0.64%
Shanghai Composite up 1.01 %
FTSE-100 down 1.01%
DAX-30 down 2.05%
PRE-MARKET SECTOR WATCH
(+/-) Large cap tech: mixed
(+/-) Chip stocks: mixed
(-) Software stocks: unchanged to lower
(+/-) Hardware stocks: mixed
(-) Internet stocks: lower
(+/-) Drug stocks: mixed
(-) Financial stocks: lower
(-) Retail stocks: unchanged to lower
(-) Industrial stocks: unchanged to lower
(-) Airlines: lower
(+/-) Autos: mixed
(+) ACHN (+12.0%) Phase 2 trial of hepatitis C virus drug achieves primary endpoint
(+) ATOS (+20.2%) Thermo Fisher Scientific to distribute its FullCyte Breast Aspirator device
(+) RIOM (+14.8%) TAHO buys co for C$4.00 per share
(+) L (+2.6%) Q4 EPS tops Street view
(+) CGA (+30.7%) Reports fiscal Q2 results; provides strong Q3 guidance
(+) GALE (+4.8%) Enrolls 700th patient in breast cancer trial; sees final enrollment by end Q1
(+) CGEN (+4.3%) Releases data on cancer immunotherapy study
(+) GTE (+1.8%) Cuts 2015 oil exploration, development budget by 55%
(+) MAS (+3.2%) Q4 earnings top estimates
(+) CONN (+4.5%) Stifel Nicolaus upgrades to buy vs hold
(+) MPAA (+1.9%) Fiscal Q3 EPS, revenue exceeds estimates
(+) MOS (+1.5%) Morgan Stanley upgrades to overweight vs equalweight
(+) CJES (+2.1%) Cuts NBR acquisition price by $250 million
(-) DO (-8.9%) Reports mixed Q4, suspends special dividend on downturn
(-) SOHU (-8.4%) Swings to Q4 loss as spending increases
(-) FSC (-14.4%) Reports fiscal Q1 results
(-) EXXI (-4.2%) Reports mixed fiscal Q2 results
(-) RGLS (-15.6%) Reports results from clinical study on hepatitis C drug
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.